Published by ECOMNEWS on September 1st, 2015 Publihed by BIOTECHFINANCES on September 4th, 2015 Published by Heraultjuridique.com on September 7th, 2015
Review in Languedoc-Roussillon Magazine, L’accent du Sud, N°38, p9” on Medical Research: “Nanoparticles to fight cancer”.
Increase of capital funding of NanoMedSyn for internal R &D in lysosomal diseases and cancer.
NanoMedSyn signs a 3-year cooperative grant in the program «Program Nanotechnologies and Nanosystems (P2N)”, with Agence Nationale de la Recherche: “BIOSIPHARM: Biosafety of mesoporous silica nanoparticles according to their surface coverage and establishing standards for evaluation”. Partners: Institute Charles Gerhardt, CNRS UMR 5253, directed by Pr Jean-Marie Devoisselle, Montpellier 34, and IBEB/SBTN, directed of Dr
NanoMedSyn signs a 2-year cooperative grant in the program « Partner Research and Therapeutic Innovation (RPIB)”, with Agence Nationale de la Recherche: “LYSOPROD: Neoglycoenzyme for the therapy of lysosomal disease”. Partners: IBMM UMR 5247, Pr A. Morère, CNRS UPS 3044 laboratory directed by Dr Martine Cérutti, St Christol (30), and INSERM U845 Dr Catherine Caillaud,